Calcium antagonist lacidipine slows down progression of asymptomatic carotid atherosclerosis: principal results of the European Lacidipine Study on Atherosclerosis (ELSA), a randomized, double-blind, long-term trial (Q44205741)
Jump to navigation
Jump to search
scientific article published in November 2002
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Calcium antagonist lacidipine slows down progression of asymptomatic carotid atherosclerosis: principal results of the European Lacidipine Study on Atherosclerosis (ELSA), a randomized, double-blind, long-term trial |
scientific article published in November 2002 |
Statements
1 reference
Calcium antagonist lacidipine slows down progression of asymptomatic carotid atherosclerosis: principal results of the European Lacidipine Study on Atherosclerosis (ELSA), a randomized, double-blind, long-term trial (English)
1 reference
Giuseppe Mancia
1 reference
Alberto Zanchetti
1 reference
M Gene Bond
1 reference
Michael Hennig
1 reference
Albrecht Neiss
1 reference
Cesare Dal Palù
1 reference
Lennart Hansson
1 reference
Bruno Magnani
1 reference
Karl-Heinz Rahn
1 reference
John L Reid
1 reference
Josè Rodicio
1 reference
Michel Safar
1 reference
Lothar Eckes
1 reference
Paolo Rizzini
1 reference
European Lacidipine Study on Atherosclerosis investigators
1 reference
1 November 2002
1 reference
1 reference
Identifiers
1 reference